Literature DB >> 15172435

Pathogenesis of human cytomegalovirus infection and cellular targets.

Giuseppe Gerna1, Fausto Baldanti, M Grazia Revello.   

Abstract

In acquired immunodeficiency syndrome patients with human cytomegalovirus (HCMV), disseminated infection, and end-organ disease, autopsy findings show a generalized HCMV infection of endothelial cells. On the other hand, immunocompromised transplanted patients show presence of virus and virus products in peripheral blood leukocytes (PBL), when affected by a disseminated HCMV infection. All diagnostic assays are based on the detection of virus and viral components in PBL or whole blood, including polymorphonuclear leukocytes and monocytes. The interplay between endothelial cells and leukocytes represents the pathogenetic basis for all clinical syndromes originating during disseminated HCMV infections and is the trigger for the transmission of HCMV from mother to fetus during primary infections of pregnant women. The two biologic properties of endothelial cell tropism and leukocyte (polymorphonuclear- and monocyte-) tropism are shared by all recent clinical HCMV isolates, whereas they are missing in laboratory-adapted strains. The potential role of HCMV in the pathogenesis of atherosclerosis both in the immunocompetent (after angioplasty) and the heart transplant patient is receiving support from seroepidemiologic findings, in vivo animal models, in vitro data, and also some clinical observations. The interaction of endothelial cells and leukocytes with subsequent spreading of infection to smooth muscle cells may be a major pathogenetic mechanism at the basis of this important vascular disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172435     DOI: 10.1016/j.humimm.2004.02.009

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  56 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

Review 2.  Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.

Authors:  Aswani D Vadlapudi; Ramya K Vadlapatla; Ashim K Mitra
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2012-04

3.  Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores.

Authors:  Ronit Sharon-Friling; Joseph Goodhouse; Anamaris M Colberg-Poley; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-29       Impact factor: 11.205

4.  The tegument protein UL71 of human cytomegalovirus is involved in late envelopment and affects multivesicular bodies.

Authors:  Martin Schauflinger; Daniela Fischer; Andreas Schreiber; Meike Chevillotte; Paul Walther; Thomas Mertens; Jens von Einem
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

5.  Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion.

Authors:  Brent J Ryckman; Michael A Jarvis; Derek D Drummond; Jay A Nelson; David C Johnson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  UL26-deficient human cytomegalovirus produces virions with hypophosphorylated pp28 tegument protein that is unstable within newly infected cells.

Authors:  Joshua Munger; Dong Yu; Thomas Shenk
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2016-08-04       Impact factor: 3.616

8.  Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy.

Authors:  Joshua Munger; Bryson D Bennett; Anuraag Parikh; Xiao-Jiang Feng; Jessica McArdle; Herschel A Rabitz; Thomas Shenk; Joshua D Rabinowitz
Journal:  Nat Biotechnol       Date:  2008-09-28       Impact factor: 54.908

9.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors.

Authors:  Brent J Ryckman; Marie C Chase; David C Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.